HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1-independent cholesterol efflux pathway.

Abstract
Tangier disease (TD) is a human genetic disorder associated with defective apolipoprotein-I-induced lipid efflux and increased atherosclerotic susceptibility. It has been linked to mutations in the ATP-binding cassette protein A1 (ABCA1). Here we describe the establishment of permanent Tangier cell lines using telomerase. Ectopic expression of the catalytic subunit of human telomerase extended the life span of control and TD skin fibroblasts, and (in contrast to immortalization procedures using viral oncogenes) did not impair apolipoprotein A-I-induced lipid efflux. The key characteristics of TD fibroblasts (reduced cholesterol and phospholipid efflux) were observed both in primary and telomerase-immortalized fibroblasts from two unrelated homozygous patients. Surprisingly, the apolipoprotein-inducible cholesterol efflux in TD cells was significantly improved after immortalization (up to 40% of normal values). In contrast to ABCA1-dependent cholesterol efflux, this efflux was not inhibited by brefeldin A, glybenclamide, or intracellular ATP depletion but was inhibited in the presence of cytochalasin D. Apolipoprotein A-I-dependent cholesterol efflux was inversely correlated with the population doubling number in cell culture and was inhibited up to 40% in near-senescent normal diploid fibroblasts. This inhibition was completely reversed by telomerase. Thus ectopic expression of telomerase is a way to circumvent the lack of critical experimental material and represents a major improvement for studying cholesterol efflux pathways in lipid disorders. Our findings indicate the existence of an ABCA1-independent but cytoskeleton-dependent cholesterol removal pathway that may help to prevent early atherosclerosis in Tangier disease but may also be sensitive to aging phenomena ex vivo and possibly in vivo.
AuthorsMichael Walter, Nicholas R Forsyth, Woodring E Wright, Jerry W Shay, Michael G Roth
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 20 Pg. 20866-73 (May 14 2004) ISSN: 0021-9258 [Print] United States
PMID15001567 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • ABCA1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters
  • Apolipoprotein A-I
  • Apolipoprotein A-II
  • DNA-Binding Proteins
  • Phospholipids
  • Brefeldin A
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Cholesterol
  • Telomerase
  • Glyburide
Topics
  • 8-Bromo Cyclic Adenosine Monophosphate (pharmacology)
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters (metabolism)
  • Apolipoprotein A-I (biosynthesis, metabolism)
  • Apolipoprotein A-II (metabolism)
  • Biological Transport
  • Brefeldin A (pharmacology)
  • Cell Line
  • Cholesterol (metabolism)
  • DNA-Binding Proteins
  • Fibroblasts (drug effects, metabolism)
  • Glyburide (pharmacology)
  • Humans
  • Kinetics
  • Phospholipids (metabolism)
  • Skin (metabolism, pathology)
  • Tangier Disease (metabolism, pathology)
  • Telomerase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: